Literature DB >> 17209665

Ocular adverse effects associated with systemic medications : recognition and management.

Ricardo M Santaella1, Frederick W Fraunfelder.   

Abstract

This article reviews several retrospective case series and reported adverse events regarding common ocular adverse effects related to systemic therapy. It is not intended as a comprehensive summary of these well described adverse drug reactions, nor is it intended to cover the complete spectrum of all ocular adverse effects of systemic therapy. Many systemic drugs may produce ocular toxicity, including bisphosphonates, topiramate, vigabatrin, isotretinoin and other retinoids, amiodarone, ethambutol, chloroquine and hydroxychloroquine, tamoxifen, quetiapine, cyclo-oxygenase (COX)-2 inhibitors, erectile dysfunction agents and some herbal medications. For this review, the certainty of the adverse effect profile of each medication was evaluated according to the WHO Causality Assessment Guide.A certain relationship has been established for pamidronate and alendronate as causes of scleritis, uveitis, conjunctivitis and blurred vision. Topiramate has been established as adversely causing symptoms consistent with acute angle-closure glaucoma, typically bilateral. Vigabatrin has been shown to cause bilateral irreversible visual field defects attributed to underlying medication-induced retinal pathology. Isotretinoin should be considered in the differential diagnosis of any patient with pseudotumour cerebri. Patients taking amiodarone and hydroxychloroquine should be monitored and screened regularly for development of optic neuropathy and maculopathy, respectively. Sildenafil has been reported to cause several changes in visual perception and is a possible, not yet certain, cause of anterior ischaemic optic neuropathy. Patients taking tamoxifen should also be monitored for development of dose-dependent maculopathy and decreased colour vision. COX-2 inhibitors should be included in the differential diagnosis of reversible conjunctivitis. Several herbal medications including canthaxanthine, chamomile, datura, Echinacea purpurea, Ginkgo biloba and liquorice have also been associated with several ocular adverse effects. It is the role of all healthcare professionals to detect, treat and educate the public about adverse reactions to medications as they are an important health problem.

Entities:  

Mesh:

Year:  2007        PMID: 17209665     DOI: 10.2165/00003495-200767010-00006

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  93 in total

1.  Vitamin A intoxication as a cause of pseudotumor cerebri.

Authors:  G MORRICE; W H HAVENER; F KAPETANSKY
Journal:  JAMA       Date:  1960-08-20       Impact factor: 56.272

2.  Isoniazid as a cause of optic neuritis and atrophy.

Authors:  I KASS; W MANDEL; H COHEN; S H DRESSLER
Journal:  J Am Med Assoc       Date:  1957-08-17

3.  The role of copper on ethambutol's antimicrobial action and implications for ethambutol-induced optic neuropathy.

Authors:  S F Kozak; C B Inderlied; H Y Hsu; K B Heller; A A Sadun
Journal:  Diagn Microbiol Infect Dis       Date:  1998-02       Impact factor: 2.803

4.  The new antiepileptic drugs: a systematic review of their efficacy and tolerability.

Authors:  A G Marson; Z A Kadir; J L Hutton; D W Chadwick
Journal:  Epilepsia       Date:  1997-08       Impact factor: 5.864

Review 5.  Diversity of GABA receptors in the vertebrate outer retina.

Authors:  B A Mustafa
Journal:  Trends Neurosci       Date:  1995-03       Impact factor: 13.837

Review 6.  The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology?

Authors:  I O Haefliger; P Meyer; J Flammer; T F Lüscher
Journal:  Surv Ophthalmol       Date:  1994 Sep-Oct       Impact factor: 6.048

7.  Transient myopia associated with vaginal sulfanilamide suppositories.

Authors:  I A Chirls; J W Norris
Journal:  Am J Ophthalmol       Date:  1984-07-15       Impact factor: 5.258

Review 8.  Ocular side effects of amiodarone.

Authors:  M Mäntyjärvi; K Tuppurainen; K Ikäheimo
Journal:  Surv Ophthalmol       Date:  1998 Jan-Feb       Impact factor: 6.048

9.  Color vision in 42 Congolese patients with tuberculosis receiving ethambutol treatment.

Authors:  Wa Kaimbo D Kaimbo; Z A Bifuko; M B Longo; L Dralands; L Missotten
Journal:  Bull Soc Belge Ophtalmol       Date:  2002

10.  Bilateral optic neuropathy due to combined ethambutol and isoniazid treatment.

Authors:  G Karmon; H Savir; D Zevin; J Levi
Journal:  Ann Ophthalmol       Date:  1979-07
View more
  41 in total

1.  [Acute monocular loss of vision : Differential diagnostic considerations apart from the internistic etiological clarification].

Authors:  A Rickmann; M A Macek; P Szurman; K Boden
Journal:  Ophthalmologe       Date:  2018-08       Impact factor: 1.059

2.  Ability of non-ophthalmologist doctors to detect eyes with occludable angles using the flashlight test.

Authors:  Carolina Pelegrini Barbosa Gracitelli; Bruno Landgren; Flávia Bracale Graciani; Aline Kátia Siqueira Sousa; Augusto Paranhos; Tiago Santos Prata
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

3.  Increased bioavailability of cyclic guanylate monophosphate prevents retinal ganglion cell degeneration.

Authors:  Lauren K Wareham; Ana C Dordea; Grigorij Schleifer; Vincent Yao; Annabelle Batten; Fei Fei; Joseph Mertz; Meredith Gregory-Ksander; Louis R Pasquale; Emmanuel S Buys; Rebecca M Sappington
Journal:  Neurobiol Dis       Date:  2018-09-10       Impact factor: 5.996

4.  Bidirectional inefficacy or intolerability of thrombopoietin receptor agonists: new data and a concise review.

Authors:  Fabian Depré; Nasra Aboud; Beate Mayer; Abdulgabar Salama
Journal:  Blood Transfus       Date:  2017-01-25       Impact factor: 3.443

5.  Blue-yellow dyschromatopsia in toluene-exposed workers.

Authors:  Axel Muttray; Volkmar Wolters; Dirk-Matthias Rose
Journal:  Int Arch Occup Environ Health       Date:  2019-01-25       Impact factor: 3.015

6.  Licorice abuse: time to send a warning message.

Authors:  Hesham R Omar; Irina Komarova; Mohamed El-Ghonemi; Ahmed Fathy; Rania Rashad; Hany D Abdelmalak; Muralidhar Reddy Yerramadha; Yaseen Ali; Engy Helal; Enrico M Camporesi
Journal:  Ther Adv Endocrinol Metab       Date:  2012-08       Impact factor: 3.565

7.  Retinal nerve fiber layer and ganglion cell layer thickness in patients receiving systemic isotretinoin therapy.

Authors:  Berrak Sekeryapan; Nursel Dılek; Veysi Oner; Kemal Turkyılmaz; Mehmet Gokhan Aslan
Journal:  Int Ophthalmol       Date:  2013-01-23       Impact factor: 2.031

Review 8.  Ocular toxicity from systemically administered xenobiotics.

Authors:  Mitan R Gokulgandhi; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-07-18       Impact factor: 4.481

Review 9.  Zebrafish--on the move towards ophthalmological research.

Authors:  J Chhetri; G Jacobson; N Gueven
Journal:  Eye (Lond)       Date:  2014-02-07       Impact factor: 3.775

10.  Neurotransmitter alterations in embryonic succinate semialdehyde dehydrogenase (SSADH) deficiency suggest a heightened excitatory state during development.

Authors:  Erwin E W Jansen; Eduard Struys; Cornelis Jakobs; Elizabeth Hager; O Carter Snead; K Michael Gibson
Journal:  BMC Dev Biol       Date:  2008-11-28       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.